Literature DB >> 17160668

[Metabolic syndrome and erectile dysfunction. Epidemiologic associations and pathogenetic links].

A Wirth1, M Manning, H Büttner.   

Abstract

There is abundant evidence for the association between erectile dysfunction (ED) and the traditional atherosclerotic risk factors, such as dyslipidemia, hypertension, glucose intolerance, and obesity, that make up the metabolic syndrome. Recent findings have demonstrated a linear relationship between the number of these risk factors and the prevalence of ED. There is also growing evidence that endothelial dysfunction characterized by decreased bioavailability of nitrogen monoxide (NO) and a proinflammatory, prothrombotic, and proliferative phenotype is the common pathogenetic pathway linking ED to peripheral vascular diseases. Since ED often occurs several years before any clinical manifestation of systemic cardiovascular disease, ED should be seen as a warning of early atherosclerotic disease and an opportunity for doctor and patient to initiate preventive measures.

Entities:  

Mesh:

Year:  2007        PMID: 17160668     DOI: 10.1007/s00120-006-1244-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  38 in total

1.  Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction.

Authors:  K Sairam; E Kulinskaya; G B Boustead; D C Hanbury; T A McNicholas
Journal:  BJU Int       Date:  2001-07       Impact factor: 5.588

2.  High proportions of erectile dysfunction in men with the metabolic syndrome.

Authors:  Katherine Esposito; Francesco Giugliano; Emilia Martedì; Giovanni Feola; Raffaele Marfella; Massimo D'Armiento; Dario Giugliano
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

3.  Sexual function in men with diabetes type 2: association with glycemic control.

Authors:  J H Romeo; A D Seftel; Z T Madhun; D C Aron
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

Review 4.  Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors.

Authors:  Frank Sommer; Wolfgang Schulze
Journal:  World J Urol       Date:  2005-11-05       Impact factor: 4.226

Review 5.  Erectile dysfunction: interrelationship with the metabolic syndrome.

Authors:  Glenn Matfin; Ali Jawa; Vivian A Fonseca
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

Review 6.  Obesity, the metabolic syndrome, and sexual dysfunction.

Authors:  K Esposito; D Giugliano
Journal:  Int J Impot Res       Date:  2005 Sep-Oct       Impact factor: 2.896

7.  Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction.

Authors:  S W Kim; J Paick; D W Park; I Chae; B Oh
Journal:  Urology       Date:  2001-09       Impact factor: 2.649

8.  Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.

Authors:  Francesco Montorsi; Alberto Briganti; Andrea Salonia; Patrizio Rigatti; Alberto Margonato; Andrea Macchi; Stefano Galli; Paolo M Ravagnani; Piero Montorsi
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

9.  Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study.

Authors:  Maple M Fung; Richele Bettencourt; Elizabeth Barrett-Connor
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

Review 10.  Metabolic syndrome, endothelial dysfunction, and erectile dysfunction: association and management.

Authors:  Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

View more
  3 in total

Review 1.  [Primary and secondary prevention of erectile dysfunction].

Authors:  A Kaminsky; H Sperling; G Popken
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

2.  [Lifestyle, erectile dysfunction, hormones and metabolic syndrome. Opportunities for gender-specific prevention for men].

Authors:  F Sommer; M J Mathers
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

Review 3.  [Is rehabilitation of erectile function following pelvic surgery reasonable? Review of the literature: from sports to PDE5 inhibitors].

Authors:  M J Mathers; T Klotz; W Vahlensieck; M Zellner; G Lümmen; S Roth; H Huland; F Sommer
Journal:  Urologe A       Date:  2008-06       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.